Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

Clinical trial NCT05447910 · TERMINATED

Trial details

NCT number: NCT05447910
Sponsor: Mayo Clinic
Status: TERMINATED
Study type: OBSERVATIONAL

Breast Adenocarcinoma Invasive Breast Carcinoma Resectable Breast Carcinoma

Start date: 2022-07-21
Primary completion: 2023-09-27
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.